AI-Driven Prediction of Drug Activity Against Toxoplasma gondii: Data Augmentation and Deep Neural Networks for Limited Datasets
Artificial Intelligence Chemistry,
Journal Year:
2025,
Volume and Issue:
unknown, P. 100084 - 100084
Published: Feb. 1, 2025
Language: Английский
Next-gen senotherapeutics: AI/ML-driven strategies for aging and age-related disorders
Prashanth S. Javali,
No information about this author
Ashish Kumar,
No information about this author
S. Sarkar
No information about this author
et al.
Advances in pharmacology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 1, 2025
Language: Английский
Computer-Aided Drug Design in Research on Chinese Materia Medica: Methods, Applications, Advantages, and Challenges
Pharmaceutics,
Journal Year:
2025,
Volume and Issue:
17(3), P. 315 - 315
Published: March 1, 2025
Chinese
materia
medica
(CMM)
refers
to
the
medicinal
substances
used
in
traditional
medicine.
In
recent
years,
CMM
has
become
globally
prevalent,
and
scientific
research
on
increasingly
garnered
attention.
Computer-aided
drug
design
(CADD)
been
employed
Western
medicine
for
many
contributing
significantly
its
progress.
However,
role
of
CADD
not
systematically
reviewed.
This
review
briefly
introduces
methods
from
perspectives
computational
chemistry
(including
quantum
chemistry,
molecular
mechanics,
mechanics/molecular
mechanics)
informatics
cheminformatics,
bioinformatics,
data
mining).
Then,
it
provides
an
exhaustive
discussion
applications
these
through
rich
cases.
Finally,
outlines
advantages
challenges
research.
conclusion,
despite
current
challenges,
still
offers
unique
over
experiments.
With
development
industry
computer
science,
especially
driven
by
artificial
intelligence,
is
poised
play
pivotal
advancing
Language: Английский
Practical implementation and impact of the 4R principles in ethnopharmacology: Pursuing a more humane approach to research
Jimin Liu,
No information about this author
Xiang Zai,
No information about this author
Xiyan Tian
No information about this author
et al.
Frontiers in Pharmacology,
Journal Year:
2025,
Volume and Issue:
16
Published: March 28, 2025
Ethnopharmacology,
a
discipline
focused
on
studying
the
medicinal
use
of
natural
materials
by
humans,
plays
crucial
role
in
addressing
challenges
modern
drug
development.
However,
traditional
3R
principle-Replacement,
Reduction,
and
Refinement-have
limitations
guiding
ethical
management
animal
experimentation,
conducting
studies,
utilizing
animal-derived
ethnopharmacological
research.
To
address
these
gaps,
field
has
introduced
4R
principles,
which
expand
original
framework
adding
"Responsibility."
The
Responsibility
principle
highlights
obligation
researchers
to
consider
welfare
experimental
animals
during
all
procedures.
It
calls
for
take
accountability
their
actions
decisions,
ensuring
that
they
actively
protect
exhibit
empathy
across
species.
This
reinforces
foundation
implement
principles
effectively,
this
article
explores
dimensions
Refinement,
Replacement,
detail.
For
strategies
include
minimizing
developing
optimized,
efficient
designs,
creating
tissue
banks
recycle
samples,
improving
success
rates
modeling.
These
efforts
collectively
aim
enhance
standards
while
advancing
scientific
outcomes.
In
terms
goal
is
minimize
distress
pain
environment,
refining
operational
procedures,
strict
control
experiments
under
anesthesia,
prioritizing
non-invasive
or
minimally
invasive
techniques
data
collection.
reduce
need
exploring
alternative
solutions.
includes
substituting
vitro
vivo
ones,
using
3D
organoids
replace
organs,
applying
deep
learning
technologies
ways
decrease
use.
focuses
enhancing
researchers'
obligations
toward
welfare.
can
be
achieved
regulations
policies
governing
providing
training
technical
personnel,
promoting
awareness
practices.
introduction
implementation
provide
valuable
guidance
conduct
experimentation
research,
offering
new
insights
methodologies
support
responsible
studies.
Language: Английский
Machine learning tools for the characterization of bioactive metabolites derived from different parts of Ochrosia elliptica Labill. for the management of Alzheimer's disease
RSC Advances,
Journal Year:
2025,
Volume and Issue:
15(14), P. 10671 - 10690
Published: Jan. 1, 2025
Ochroisa
elliptica
revealed
41
compounds
using
UPLC-MS/MS
and
assessed
their
binding
affinities
to
cholinesterase
enzymes
through
molecular
docking.
A
quercetin
derivative
exhibited
the
strongest
binding.
Additionally,
dynamic
simulations
confirmed
stable
interactions.
Language: Английский